Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.
sp28 quick look at your posts from last week and can see you are desperate and sitting on a loss ,thats unfortunate but i disagree this will go to 40-50 and divi will be cancelled ,war is just starting , stay away folks from russian stocks
why is this up 120% on a this "deal" AAA? doesnt say who is this, no details on the deal, looks like it about mobile? Why even ? Not deramping, just saw this is up went to read amazing rns and im like wtf
https://themarketherald.com.au/dotz-nano-asxdtz-secures-thailand-distribution-partner-2021-12-08/
Dotz Nano (DTZ) secures its fourth distribution partner for its SARS-CoV-2 virus detection technology
lamp test as well
we droped from 54 to 48 yesterday so what ?
mixed messages, they say omicron likely to be mild so why so many in hospitals, I thought mild is when you stay at home and have flu like symptoms
https://www.voanews.com/a/south-africa-readies-hospitals-as-omicron-variant-drives-new-covid-19-wave-/6340912.html
https://www.nature.com/articles/d41586-021-00728-2
Five reasons why COVID herd immunity is probably impossible
Even with vaccination efforts in full force, the theoretical threshold for vanquishing COVID-19 looks to be out of reach.
nasty virus ,testing not going anywhere
41-fold in drop in the ability of their antibodies to neutralize the omicron variant compared to the original virus, a dramatic reduction from its performance against the original ancestral strain as well as other variants, according to a preprint of the study that hasn’t yet been peer reviewed. Vaccine-induced antibodies dropped threefold in their ability to neutralize the earlier beta variant that previously dominated South Africa, suggesting omicron is much better at evading protection.
"Current Price
UK£0.47
Fair Value
UK£1.18"
"Below Fair Value: GDR (£0.47) is trading below our estimate of fair value (£1.18)
Significantly Below Fair Value: GDR is trading below fair value by more than 20%."
"How is genedrive forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Analysis Checks 6/6
71.0%
Forecasted annual earnings growth"
"Earnings vs Savings Rate: GDR is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.9%).
Earnings vs Market: GDR is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: GDR's is expected to become profitable in the next 3 years.
Revenue vs Market: GDR's revenue (110.7% per year) is forecast to grow faster than the UK market (4.9% per year).
High Growth Revenue: GDR's revenue (110.7% per year) is forecast to grow faster than 20% per year."
"Future ROE: GDR's Return on Equity is forecast to be high in 3 years time (24.3%)"
"Insider Buying: GDR insiders have bought more shares than they have sold in the past 3 months."
GDR with lamp test is better choice than NCYT , PCR test will be a thing of the past soon
company developing LAMP test in US
"How a little-known Bay Area company helped root out the first omicron case in the U.S."
"But the emergence of the omicron variant — which is being met in California and around the world with renewed efforts to expand testing and sequencing — may bring the focus back to COVID testing yet again.
“When we launched in March 2020, we didn’t think we’d still be running testing in December 2021,” Zhou said. “As long as that demand remains high, we don’t have plans to wind that down. "
I see shift to LAMP tests in next weeks . just watch
"Experts have also said Lamp tests can be used to track new Covid-19 variant outbreaks, such as omicron."
“Through a PCR test you can make an ‘informed guess’ over whether a specimen is likely to be the new omicron variant. However, to confirm it, you have to go through further sequencing which takes more time but can be done from the original sample.
"One of the advantages of Lamp testing, as opposed to lateral flow, is that you can do sequencing directly from the original sample that was submitted for saliva testing and so there is no requirement to go back to people and get another sample, with all the delays. Those delays are problematic because if it’s a delay of several days and someone is infectious, they could have gone on to pass it to others.
“So, if you absolutely wanted to nail it as omicron and stop transmission, as UKHSA is trying to do at the moment, you need quick processes which are generally not achieved with lateral flow tests.”
and if you are in for a punt only and don't want to be "long term investor" you should have an entry and exit price whether its profit or loss, you can only blame yourself for a bad trade. If you think based on your research gdr at this mcap is overpriced ,sell, if you are willing to risk buy, simple ,stop moaning , company makes products , doesn't always mean it will sell them , that is life, a lot of competiotion, unknow problems, etc, bod is not always to blame
thats bad advice ,i remember some ii sold SNG few days before that 500% rise , that was a good laugh
bought today for 9 looks like good price on that drop gla
"The actual Genedrive announcement is that their rapid, molecular test for SARS-Covid has been submitted to the European Union authorities for a CE certification. This is one of those necessary steps to be able to market anything across the EU, a CE mark.
The interest in the test itself is significant, as the promised result is in under 8 minutes if positive and 17 minutes to prove the negative. This is of course vastly faster than PCR and so on which requires the multiplication of the virus many times from the original sample size before detection takes place. A rapid – can be done right here, right now – and accurate test would gain significant market share, that seems obvious enough. "
With the Omicron strain of the Covid-19 virus dominating the headlines, Genedrive chose a good time to submit its new rapid point of care molecular test for Covid detection for CE-IVD certification.
The Genedrive Covid kit offers a step-change in rapid molecular testing, delivering positive results as quickly as 7.5 minutes and negative results at 17 minutes, the company said.
The news sent the shares 86 per cent higher at 43.25p.
https://www.thisismoney.co.uk/money/markets/article-10272387/SMALL-CAP-MOVERS-Beowulf-John-Lewis-Hungerford.html
Thin air? I hope you're not invested in crypto then
So wait few days fo it to be updated maybe?
https://covid-19-diagnostics.jrc.ec.europa.eu/devices/detail/2524
That's your story but if the company is so bad why new or old holders keep adding here ? First thing gdr was trading at 20-30 p before the pandemic in 2017-2019 after that it was a hype and lots of volatility due to uncertainty and low float. This month company is in better position with more money and new products. Just because it failed to deliver before doesn't mean it will happen again. Past is not an indication of the future performance so anything can happen here and if there is someone interested in the gdr products they will make money eventually and sales will flow. Same as in mining shares this could be binary .boom or bust. Worst case scenario this is 20-30p good value for the company pandemic or not ,best case we have sales and can 10bag